European Union Approves New Vaccine for Ebola
Submitted by [email protected] on Mon, 06/01/2020 - 12:00 PM
The European Union approved a new vaccine to prevent Ebola virus disease (Zaire ebolavirus species) in individuals aged 1 year and older. The vaccine consists of two components, Zabdeno (Ad26.ZEBOV) and Mvabea (MVA-BN-Filo). Zabdeno is given first and Mvabea is administered approximately eight weeks later as a booster.
Content Source: European Union European Medicines Agency
Content Author: European Union European Medicines Agency